Data as of Aug 22
| -0.1162 / -4.91%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +522.22% increase from the last price of 2.25.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.